Radiation therapy is a powerful and non-invasive tool in the management of small cell lung cancer (SCLC), but radiation oncologists are not always fully integrated into the care team. In this episode, CANCER BUZZ speaks with Charles B. Simone, II, MD, FASTRO, FACRO, FACR, chief medical officer of the New York Proton Center and radiation oncologist at Memorial Sloan Kettering Cancer Center, about strategies to improve collaboration between radiation and medical oncology. He discusses some of the biggest barriers and greatest rewards of enhancing this partnership and expanding access to radiation therapy for SCLC.
“While we don't have large, randomized trials really telling us how the modalities should be sequenced, that really should be a discussion and personalized for each patient.” —Charles B. Simone, II, MD, FASTRO, FACRO, FACR
“After a slow 20 years of limited progress, this last half a decade has seen dramatic progress for small cell, and with that, the multidisciplinary collaboration is even more important.” —Charles B. Simone, II, MD, FASTRO, FACRO, FACR
Guest:
Charles B. Simone, II, MD, FASTRO, FACRO, FACR
Research Professor and Chief Medical Officer
New York Proton Center
Radiation Oncologist
Memorial Sloan Kettering Cancer Center
New York, NY
Resources:
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
